Thanks very much, Chair.
I'd like to talk to you, Dr. Vogel, about what Mr. Hedican is maybe referring to. I think there may be another way to look at those so-called first-time users. Realistically, we haven't discussed prevention much in this committee.
In your experience in Switzerland, or perhaps in Europe in general, have you had any opportunity to look at that specifically?